Globus Medical, Inc. (GMED) Income Statement
GMED 2025 at a glance
Fiscal year ended December 31, 2025 · U.S. dollarsGMED revenue and net income
Where GMED's revenue goes
2025Each bar shows an amount and its share of revenue. GMED kept 18.3% of revenue as net income.
GMED profit margins
GMED growth rates
to 2025| 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|
| Revenue | +16.7% | +42.2% | +30.1% | +18.4% |
| Gross profit | +33.5% | +37.7% | +28.2% | +17.0% |
| Operating income | +189.1% | +28.2% | +33.9% | +10.8% |
| Net income | +422.3% | +41.4% | +39.4% | +16.9% |
| EPS (diluted) | +27.4% | +24.6% | +22.8% | +13.7% |
1-year change and average annual growth (CAGR) over 3, 5 and 10 fiscal years. "—" when a starting value was zero or negative.
GMED quarterly EPS vs estimates
Globus Medical beat the analyst EPS estimate in 7 of the last 8 quarters. Next report: November 5, 2026 (estimate $1.20).
GMED income statement
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $2.94B | $2.52B | $1.57B | $1.02B | $958.1M | $789.0M | $785.4M | $713.0M | $636.0M | $564.0M |
| Cost of revenue | $957.8M | $1.04B | $548.2M | $263.7M | $239.2M | $217.5M | $180.0M | $159.4M | $150.5M | $134.7M |
| Gross profit | $1.98B | $1.48B | $1.02B | $759.1M | $718.9M | $571.6M | $605.4M | $553.6M | $485.5M | $429.3M |
| Research & development | $185.0M | $163.8M | $124.0M | $73.0M | $97.3M | $84.5M | $60.1M | $55.5M | $43.7M | $44.5M |
| Sales, general & admin | $1.18B | $981.0M | $643.4M | $432.1M | $408.1M | $354.8M | $354.8M | $311.6M | $267.8M | $222.2M |
| Total operating expenses | $1.50B | $1.32B | $887.2M | $531.2M | $546.9M | $460.1M | $433.4M | $384.2M | $323.7M | $275.1M |
| Operating income | $479.8M | $166.0M | $133.1M | $228.0M | $172.0M | $111.4M | $172.0M | $169.3M | $161.8M | $154.1M |
| Interest income | — | — | — | — | — | — | $17.5M | $13.6M | $7.5M | $2.6M |
| Interest expense | — | $4.2M | $20.1M | $14.2M | $9.3M | $14.0M | $17.4M | $13.3M | $6.6M | $3.1M |
| Income before taxes | $609.9M | $120.7M | $165.4M | $243.0M | $180.4M | $125.9M | $189.9M | $188.6M | $169.9M | $157.3M |
| Income taxes | $72.0M | $17.7M | $42.5M | $52.9M | $31.2M | $23.6M | $34.7M | $32.1M | $62.6M | $52.9M |
| Net income | $537.9M | $103.0M | $122.9M | $190.2M | $149.2M | $102.3M | $155.2M | $156.5M | $107.3M | $104.3M |
| EBITDA | $886.7M | $473.7M | $346.6M | $304.5M | $264.7M | $178.3M | $229.5M | $218.5M | $205.4M | $193.0M |
| EPS (diluted) | $4.00 | $3.14 | $2.33 | $2.07 | $2.04 | $1.43 | $1.69 | $1.67 | $1.30 | $1.19 |
| Gross margin | 67.4% | 58.9% | 65.1% | 74.2% | 75.0% | 72.4% | 77.1% | 77.6% | 76.3% | 76.1% |
| Operating margin | 16.3% | 6.6% | 8.5% | 22.3% | 17.9% | 14.1% | 21.9% | 23.7% | 25.4% | 27.3% |
| Net margin | 18.3% | 4.1% | 7.8% | 18.6% | 15.6% | 13.0% | 19.8% | 21.9% | 16.9% | 18.5% |
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 | Jun '24 | Mar '24 | Dec '23 | Sep '23 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $789.6M | $759.9M | $826.4M | $769.0M | $745.3M | $598.1M | $657.3M | $625.7M | $629.7M | $606.7M | $616.5M | $383.6M |
| Cost of revenue | $241.4M | $234.1M | $231.3M | $282.4M | $248.8M | $195.4M | $263.4M | $270.5M | $260.0M | $241.5M | $265.5M | $135.4M |
| Gross profit | $548.2M | $525.8M | $595.1M | $486.7M | $496.6M | $402.7M | $393.9M | $355.2M | $369.7M | $365.2M | $351.0M | $248.2M |
| Research & development | $36.3M | $36.5M | $73.9M | $38.1M | $40.0M | $33.1M | $33.4M | $35.4M | $37.7M | $57.3M | $52.3M | $29.3M |
| Sales, general & admin | $286.8M | $297.8M | $318.5M | $313.6M | $303.6M | $242.8M | $253.5M | $240.7M | $238.1M | $248.7M | $244.7M | $156.2M |
| Total operating expenses | $365.7M | $363.8M | $423.4M | $351.7M | $420.5M | $305.7M | $333.6M | $307.1M | $320.0M | $357.2M | $340.9M | $247.8M |
| Operating income | $182.4M | $163.6M | $171.7M | $135.0M | $76.1M | $97.0M | $60.3M | $48.1M | $49.6M | $8.0M | $10.1M | $404,000 |
| Interest expense | — | $5.4M | — | $1.5M | $693,000 | — | $815,000 | $775,000 | $2.3M | $1.9M | $2.6M | $7.9M |
| Income before taxes | $189.8M | $157.1M | $174.1M | $144.0M | $188.2M | $103.7M | $24.7M | $57.0M | $47.6M | −$8.6M | $25.0M | $2.5M |
| Income taxes | $38.2M | $32.8M | $33.4M | $25.0M | −$14.7M | $28.2M | −$1.8M | $5.2M | $15.8M | −$1.4M | $10.0M | $1.5M |
| Net income | $151.6M | $124.3M | $140.6M | $119.0M | $202.8M | $75.5M | $26.5M | $51.8M | $31.8M | −$7.1M | $15.0M | $998,000 |
| EBITDA | $259.3M | $226.9M | $244.4M | $215.1M | $193.4M | $164.1M | $145.3M | $115.9M | $126.4M | $84.8M | $97.1M | $86.3M |
| EPS (diluted) | $1.34 | $1.12 | $1.28 | $1.18 | $0.86 | $0.68 | $0.84 | $0.83 | $0.75 | $0.72 | $0.60 | $0.57 |
| Gross margin | 69.4% | 69.2% | 72.0% | 63.3% | 66.6% | 67.3% | 59.9% | 56.8% | 58.7% | 60.2% | 56.9% | 64.7% |
| Operating margin | 23.1% | 21.5% | 20.8% | 17.6% | 10.2% | 16.2% | 9.2% | 7.7% | 7.9% | 1.3% | 1.6% | 0.1% |
| Net margin | 19.2% | 16.4% | 17.0% | 15.5% | 27.2% | 12.6% | 4.0% | 8.3% | 5.0% | −1.2% | 2.4% | 0.3% |
Quarterly columns are labeled by the month the quarter ended. Figures in U.S. dollars as reported in GMED's financial statements (latest annual report filed February 24, 2026); data from EODHD. Sales, general & administrative expenses include sales and marketing.
GMED financial results
In fiscal year 2025 (ended December 31, 2025), Globus Medical reported revenue of $2.9 billion, up 16.7% from the year before. It had net income of $537.9 million (up 422.3%), a net profit margin of 18.3%. Diluted earnings per share came to $4.00. Over five years revenue grew at an average rate of 30.1% a year.
See the GMED stock overview for the latest quote and news, or the GMED chart for price history and technical indicators.
GMED income statement FAQ
What is Globus Medical's annual revenue?
Globus Medical reported total revenue of $2.9 billion for fiscal year 2025, which ended on December 31, 2025. That was up 16.7% from $2.5 billion the previous year.
Is Globus Medical profitable?
Yes. Globus Medical reported net income of $537.9 million in fiscal 2025, a net profit margin of 18.3%; its operating margin was 16.3%.
What is Globus Medical's gross margin?
Globus Medical's gross margin was 67.4% in fiscal 2025: for every $100 of revenue, Globus Medical kept $67 after the direct cost of its products and services.
How much does Globus Medical spend on research and development?
Globus Medical spent $185.0 million on research and development in fiscal 2025, 6.3% of revenue.
How fast is Globus Medical growing?
Revenue grew 30.1% a year on average over the last five fiscal years, from $789.0 million to $2.9 billion.
What are Globus Medical's earnings per share?
Globus Medical earned $4.00 per diluted share in fiscal 2025, compared with $3.14 a year earlier.
When will Globus Medical report its next earnings?
Globus Medical is expected to report results for the quarter ending September 30, 2026 on November 5, 2026 after the market closes.
When does Globus Medical's fiscal year end?
Globus Medical's fiscal year ends in December. The latest annual report covers the year ended December 31, 2025 and was filed on February 24, 2026.